Tyrosine kinase inhibitors in chronic myeloid leukemia.
Sawyers
C L
CL
Department of Medicine and Molecular Biology Institute, University of California Los Angeles, USA.
Druker
B
B
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000201:enzymology* / Q000628:therapy; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D007372:Interferons; D011505:Protein-Tyrosine Kinases